358
Views
4
CrossRef citations to date
0
Altmetric
Research Article

In vitro and in vivo estrogenic activity of triclosan

&

References

  • Aiello, A. E., E. L. Larson, and S. B. Levy. 2007. Consumer antibacterial soaps: Effective or just risky? Clin. Infect. Dis. 45 (2):S137–S147. doi:10.1086/519255.
  • Allmyr, M., M. Adolfsson-Erici, M. S. McLachlan, and G. Sandborgh-Englund. 2006a. Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. Sci. Total Environ. 372 (1):87–93. doi:10.1016/j.scitotenv.2006.08.007.
  • Allmyr, M., M. S. McLachlan, G. Sandborgh-Englund, and M. Adolfsson-Erici. 2006b. Determination of triclosan as its pentafluorobenzoyl ester in human plasma and milk using electron capture negative ionization mass spectrometry. Anal. Chem. 78:6542–46. doi:10.1021/ac060666x.
  • Allmyr, M., G. Panagiotidis, E. Sparve, U. Diczfalusy, and G. Sandborgh-Englund. 2009. Human exposure to triclosan via toothpaste does not change CYP3A4 activity or plasma concentrations of thyroid hormones. Basic Clin. Pharmacol. Toxicol. 105:339–44. doi:10.1111/j.1742-7843.2009.00455.x.
  • Autrup, H., F. A. Barile, S. C. Berry, B. J. Blaauboer, A. Boobis, H. Bolt, C. J. Borgert, W. Dekant, D. Dietrich, J. L. Domingo, et al. 2020. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs? Journal of Toxicology and Environmental Health, Part A 83 (13–14):485–94. doi:10.1080/15287394.2020.1756592.
  • Brausch, J. M., and G. M. Rand. 2011. A review of personal care products in the aquatic environment: Environmental concentrations and toxicity. Chemosphere 82 (11):1518–32. doi:10.1016/j.chemosphere.2010.11.018.
  • Calafat, A. M., X. Ye, L. Y. Wong, J. A. Reidy, and L. L. Needham. 2008. Urinary concentrations of triclosan in the U.S. population: 2003-2004. Environ. Health. Perspect. 116 (3):303–07. doi:10.1289/ehp.10768.
  • Carrasco-Ruiz, A., O. Sánchez-García, P. Pacheco, M. Martínez-Gómez, E. Cuevas-Romero, and F. Castelán. 2021. Differential estrogen-related responses in myofiber cross-sectional area of pelvic floor muscles in female rats. Gynecol Endocrinol. Jan 27:1–6.
  • Chae, S., B. Y. Ahn, K. Byun, Y. M. Cho, M. H. Yu, B. Lee, D. Hwang, and K. S. Park. 2013. A systems approach for decoding mitochondrial retrograde signaling pathways. Sci. Signal 6 (264):rs4. doi:10.1126/scisignal.2003266.
  • Chen, H., J. Xiao, G. Hu, J. Zhou, H. Xiao, and X. Wang. 2002. Estrogenicity of organophosphorus and pyrethroid pesticides. J. Toxicol. Environ. Health A 65 (19):1419–35. doi:10.1080/00984100290071243.
  • Chung, B. Y., M. Kyung, S. K. Lim, S. M. Choi, D. S. Lim, S. J. Kwack, H. S. Kim, and B. M. Lee. 2013. Uterotrophic and Hershberger assays for endocrine disruption properties of plastic food contact materials polypropylene (PP) and polyethylene terephthalate (PET). J. Toxicol. Environ. Health A 76 (10):624–34. doi:10.1080/15287394.2013.801767.
  • Cullinan, M. P., J. E. Palmer, A. D. Carle, M. J. West, B. Westerman, and G. J. Seymour. 2015. The influence of a triclosan toothpaste on adverse events in patients with cardiovascular disease over 5-years. Sci. Total Environ. 508:546–52. doi:10.1016/j.scitotenv.2014.11.052.
  • Dirtu, A. C., L. Roosens, T. Geens, A. Gheorghe, H. Neels, and A. Covaci. 2008. Simultaneous determination of bisphenol A, triclosan, and tetrabromobisphenol A in human serum using solid-phase extraction and gas chromatography-electron capture negative-ionization mass spectrometry. Anal. Bioanal. Chem. 391 (4):1175–81. doi:10.1007/s00216-007-1807-9.
  • Ena, L., J. S. Lim, J. Y. Son, Y. J. Park, Y. H. Lee, J. Y. Kim, S. J. Kwack, B. M. Lee, M. Ahn, and H. S. Kim. 2018. Evaluation of subchronic exposure to triclosan on hepatorenal and reproductive toxicities in prepubertal male rats. J. Toxicol. Environ. Health A 81 (11):421–31. doi:10.1080/15287394.2018.1451188.
  • Gee, R. H., A. Charles, N. Taylor, and P. D. Darbre. 2008. Oestrogenic and androgenic activity of triclosan in breast cancer cells. J. Appl. Toxicol. 28 (1):78–91. doi:10.1002/jat.1316.
  • Gibson, L. L., J. B. Rose, C. N. Haas, C. P. Gerba, and P. A. Rusin. 2002. Quantitative assessment of risk reduction from hand washing with antibacterial soaps. J. Appl Microbiol. 92:136s–143s. doi:10.1046/j.1365-2672.92.5s1.17.x.
  • Halden, R. U. 2014. On the need and speed of regulating triclosan and triclocarban in the United States. Environ. Sci. Technol. 48 (7):3603–11. doi:10.1021/es500495p.
  • Han, S. Y., H. J. Moon, H. S. Kim, C. K. Kim, J. H. Shin, S. D. Oh, S. J. Jang, and K. L. Park. 2000. No estrogenic activity of phthalate esters in ovariectomized rat uterotrophic assay. J. Appl. Pharmacol. 8:147–52.
  • Henry, N. D., and P. A. Fair. 2013. Comparison of in vitro cytotoxicity, estrogenicity and anti-estrogenicity of triclosan, perfluorooctane sulfonate and perfluorooctanoic acid. J. Appl. Toxicol. 33 (4):265–72. doi:10.1002/jat.1736.
  • Huang, D. W., B. T. Sherman, and R. A. Lempicki. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4 (1):44–57. doi:10.1038/nprot.2008.211.
  • Huang, H., G. Du, W. Zhang, J. Hu, D. Wu, L. Song, Y. Xia, and X. Wang. 2014. The in vitro estrogenic activities of triclosan and triclocarban. J. Appl. Toxicol. 34 (9):1060–67. doi:10.1002/jat.3012.
  • Ishibashi, H., N. Matsumura, M. Hirano, M. Matsuoka, H. Shiratsuchi, Y. Ishibashi, Y. Takao, and K. Arizono. 2004. Effects of triclosan on the early life stages and reproduction of medaka Oryzias latipes and induction of hepatic vitellogenin. Aquat. Toxicol 67 (2):167–79. doi:10.1016/j.aquatox.2003.12.005.
  • Jones, R. D., H. B. Jampani, J. L. Newman, and A. S. Lee. 2000. Triclosan: A review of effectiveness and safety in health care settings. Am. J. Infect. Control 28 (2):184–96. doi:10.1067/mic.2000.102378.
  • Jung, E. M., B. S. An, K. C. Choi, and E. B. Jeung. 2012. Potential estrogenic activity of triclosan in the uterus of immature rats and rat pituitary GH3 cells. Toxicol. Lett 208 (2):142–48. doi:10.1016/j.toxlet.2011.10.017.
  • Kim, H. S., S. Y. Han, S. D. Yoo, B. M. Lee, and K. L. Park. 2001. Potential estrogenic effects of bisphenol-A estimated by in vitro and in vivo combination assays. J. Toxicol. Sci. 26 (3):111–18. doi:10.2131/jts.26.111.
  • Kim, H. S., T. S. Kang, I. H. Kang, T. S. Kim, H. J. Moon, I. Y. Kim, H. Ki, K. L. Park, B. M. Lee, S. D. Yoo, et al.. 2005a. Validation study of OECD rodent uterotrophic assay for the assessment of estrogenic activity in Sprague-Dawley immature female rats. J. Toxicol. Environ. Health A 68 (23–24):2249–62. doi:10.1080/15287390500182354.
  • Kim, K. B., S. H. Kim, S. Y. Um, M. W. Chung, J. S. Oh, S. C. Jung, T. S. Kim, H. J. Moon, S. Y. Han, H. Y. Oh, et al.. 2009. Metabolomics approach to risk assessment: Methoxyclor exposure in rats. J. Toxicol. Environ. Health A 72 (21–22):1352–68. doi:10.1080/15287390903212550.
  • Kim, S. J. 2001. Microarray gene expression analysis. Korean J. Clin. Microbiol. 4:82–86.
  • Kim, S. S., S. J. Kwack, R. D. Lee, K. J. Lim, G. S. Rhee, J. H. Seok, B. H. Kim, Y. H. Won, G. S. Lee, E. B. Jeung, et al.. 2005b. Assessment of estrogenic and androgenic activities of tetramethrin in vitro and in vivo assays. J. Toxicol. Environ. Health A 68 (23–24):2277–89. doi:10.1080/15287390500182453.
  • Kwack, S. J., O. Kwon, H. S. Kim, S. S. Kim, S. H. Kim, K. H. Sohn, R. D. Lee, C. H. Park, E. B. Jeung, B. S. An, et al.. 2002. COMPARATIVE EVALUATION OF ALKYLPHENOLIC COMPOUNDS ON ESTROGENIC ACTIVITY in vitro AND IN VIVO. In Vivo. J. Toxicol. Environ. Health A 65 (5–6):419–31. doi:10.1080/15287390252808082.
  • Kwon, J. T., Y. S. Yang, M. S. Kang, G. B. Seo, D. H. Lee, M. J. Yang, I. Shim, H. M. Kim, P. Kim, K. Choi, et al.. 2013. Pulmonary toxicity screening of triclosan in rats after intratracheal instillation. J. Toxicol. Sci. 38 (3):471–75. doi:10.2131/jts.38.471.
  • Lee, H. R., K. A. Hwang, K. H. Nam, H. C. Kim, and K. C. Choi. 2014. Progression of breast cancer cells was enhanced by endocrine-disrupting chemicals, triclosan and octylphenol, via an estrogen receptor-dependent signaling pathway in cellular and mouse xenograft models. Chem. Res. Toxicol. 27 (5):834–42. doi:10.1021/tx5000156.
  • Louis, G. W., D. R. Hallinger, M. J. Braxton, A. Kamel, and T. E. Stoker. 2017. Effects of chronic exposure to triclosan on reproductive and thyroid endpoints in the adult Wistar female rat. Journal of Toxicology and Environmental Health, Part A 80 (4):236–49. doi:10.1080/15287394.2017.1287029.
  • Louis, G. W., D. R. Hallinger, and T. E. Stoker. 2013. The effect of triclosan on the uterotrophic response to extended doses of ethinyl estradiol in the weanling rat. Reprod. Toxicol. 36:71–77. doi:10.1016/j.reprotox.2012.12.001.
  • McMurry, L. M., M. Oethinger, and S. B. Levy. 1998. Triclosan targets lipid synthesis. Nature 394 (6693):531–32. doi:10.1038/28970.
  • MFDS (Ministry of Food and Drug Safety). 2015. Triclosan.
  • Morizane, M., Y. Kawasaki, T. Miura, K. Yagi, S. Esumi, Y. Kitamura, and T. Sendo. 2015. Photoinitiator-initiated estrogenic activity in human breast cancer cell line MCF-7. J. Toxicol. Environ. Health A 78 (23–24):1450–60. doi:10.1080/15287394.2015.1094431.
  • Odum, J., P. A. Lefevre, S. Tittensor, D. Paton, E. J. Routledge, N. A. Beresford, J. P. Sumpter, and J. Ashby. 1997. The rodent uterotrophic assay: Critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay. Regul. Toxicol. Pharmacol. 25 (2):176–88. doi:10.1006/rtph.1997.1100.
  • OECD (Organisation for Economic Co-operation and Development). 2007. Test No. 440: Uterotrophic Bioassay in Rodents.
  • Owens, W., and H. B. W. M. Koëter. 2003. The OECD program to validate the rat uterotrophic bioassay: An overview. Environ. Health Perspect. 111 (12):1527–29. doi:10.1289/ehp.6413.
  • Parrott, J. L., and D. T. Bennie. 2009. Life-cycle exposure of fathead minnows to a mixture of six common pharmaceuticals and triclosan. J. Toxicol. Environ. Health A 72 (10):633–41. doi:10.1080/15287390902769428.
  • Rattan, S., C. Zhou, C. Chiang, S. Mahalingam, E. Brehm, and J. A. Flaws. 2017. Exposure to endocrine disruptors during adulthood: Consequences for female fertility. J. Endocrinol 233 (3):R109–R129. doi:10.1530/JOE-17-0023.
  • Rodricks, J. V., J. A. Swenberg, J. F. Borzelleca, R. R. Maronpot, and A. M. Shipp. 2010. Triclosan: A critical review of the experimental data and development of margins of safety for consumer products. Crit. Rev. Toxicol. 40 (5):422–84. doi:10.3109/10408441003667514.
  • Rodríguez, P. E., and M. S. Sanchez. 2010. Maternal exposure to triclosan impairs thyroid homeostasis and female pubertal development in Wistar rat offspring. J. Toxicol. Environ. Health A 73 (24):1678–88. doi:10.1080/15287394.2010.516241.
  • Ruszkiewicz, J. A., S. Li, M. B. Rodriguez, and M. Aschner. 2017. Is triclosan a neurotoxic agent? J. Toxicol. Environ. Health B 20 (2):104–17. doi:10.1080/10937404.2017.1281181.
  • Sandborgh-Englund, G., M. Adolfsson-Erici, G. Odham, and J. Ekstrand. 2006. Pharmacokinetics of triclosan following oral ingestion in humans. J. Toxicol. Environ. Health A 69 (20):1861–73. doi:10.1080/15287390600631706.
  • SCCS (Scientific Committee on Consumer Safety). 2009. Opinion on Triclosan Colipa n° P32.
  • Soto, A. M., C. Sonnenschein, K. L. Chung, M. F. Fernandez, N. Olea, and F. O. Serrano. 1995. The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environ. Health Perspect. 103:113–22.
  • Stoker, T. E., E. K. Gibson, and L. M. Zorrilla. 2010. Triclosan exposure modulates estrogen-dependent responses in the female wistar rat. Toxicol. Sci 117 (1):45–53. doi:10.1093/toxsci/kfq180.
  • Suller, M. T. E., and A. D. Russell. 2000. Triclosan and antibiotic resistance in Staphylococcus aureus. J. Antimicrob. Chemother. 46 (1):11–18. doi:10.1093/jac/46.1.11.
  • Sun, D., T. Zhao, X. Li, and Z. Zhang. 2019. Evaluation of DNA and chromosomal damage in two human HaCaT and L02 cells treated with varying triclosan concentrations. J. Toxicol. Environ. Health A 82 (7):473–82. doi:10.1080/15287394.2019.1618758.
  • Syberg, K., A. Nielsen, F. R. Khan, G. T. Banta, A. Palmqvist, and P. M. Jepsen. 2017. Microplastic potentiates triclosan toxicity to the marine copepod Acartia tonsa (Dana). J. Toxicol. Environ. Health A 80 (23–24):1369–71. doi:10.1080/15287394.2017.1385046.
  • Tang, B., Z. Li, and Z. Wang. 2021. PERK activator CCT020312 prevents inflammation-mediated osteoporosis in the ovariectomized rats. Gynecol. Endocrinol 22 ( Jan):1–9. doi:10.1080/09513590.2021.1874904.
  • Wang, C., and Y. Tian. 2015. Reproductive endocrine-disrupting effects of triclosan: Population exposure, present evidence and potential mechanisms. Environ Pollut 206:195–201. doi:10.1016/j.envpol.2015.07.001.
  • Witorsch, R. J. 2014. Critical analysis of endocrine disruptive activity of triclosan and its relevance to human exposure through the use of personal care products. Crit. Rev. Toxicol. 44 (6):535–55. doi:10.3109/10408444.2014.910754.
  • Yoon, K. S., S. M. Gu, H. J. Cha, Y. Kim, J. Yun, and J. Lee. 2020b. 25I-NBOMe, a phenethylamine derivative, induces adverse cardiovascular effects in rodents: Possible involvement of p21 (CDC42/RAC)-activated kinase 1. Drug. Chem. Toxicol. Jun 29:1–9.
  • Yoon, K. S., J. Lee, Y. Kim, S. K. Suh, and H. J. Cha. 2020a. Cardiotoxic effects of [3-[2-(diethylamino)ethyl]-1H-indol-4-yl] acetate and 3-[2-[ethyl(methyl)amino]ethyl]-1H-indol-4-ol. Toxicol. Lett. 319:40–48. doi:10.1016/j.toxlet.2019.10.022.
  • Yoon, K. S., N. Youn, H. Gu, and S. J. Kwack. 2017. Estrogenic activity of zinc pyrithione: An in vivo and in vitro study. Environ. Health Toxicol. 32:e2017004. doi:10.5620/eht.e2017004.
  • Yoon, K. S., J. Yun, Y. Kim, J. Shin, S. J. Kim, J. Seo, S. Hyun, S. K. Suh, and H. J. Cha. 2019. 2-(2,5-Dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine (25D-NBOMe) and N-(2-methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine (25C-NBOMe) induce adverse cardiac effects in vitro and. In Vivo. Toxicol. Lett. 304:50–57. doi:10.1016/j.toxlet.2019.01.004.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.